Lupin Ltd posts consolidated net profit of Rs. 542.46 crores in Q1 FY2021-22

Lupin Ltd has reported financial results for the period ended June 30, 2021.

Financial Results (Q1 FY 2021-22) - QoQ Comparison

The company has reported total income of Rs.4298.02 crores during the period ended June 30, 2021 as compared to Rs.3831.74 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.542.46 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.460.36 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.11.91 for the period ended June 30, 2021 as compared to Rs.10.11 for the period ended March 31, 2021.

Financials	Q1 FY2021-22	Q4 FY20-21	% Change
Total Income	₹ 4298.02 crs	₹ 3831.74 crs	12.17%
Net Profit	₹ 542.46 crs	₹ 460.36 crs	17.83%
EPS	₹ 11.91	₹ 10.11	17.8%

Financial Results (Q1 FY 2021-22) - YoY Comparison

The company has reported total income of Rs.4298.02 crores during the period ended June 30, 2021 as compared to Rs.3571.14 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.542.46 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.106.90 crores for the period ended June 30, 2020.

The company has reported EPS of Rs.11.91 for the period ended June 30, 2021 as compared to Rs.2.35 for the period ended June 30, 2020.

Financials	Q1 FY2021-22	Q1 FY2020-21	% Change
Total Income	₹ 4298.02 crs	₹ 3571.14 crs	20.35%
Net Profit	₹ 542.46 crs	₹ 106.90 crs	407.45%
EPS	₹ 11.91	₹ 2.35	406.81%

Commenting on the results, Mr. Nilesh Gupta, Managing Director, Lupin Limited said, "While the quarter's profits were bolstered by the Boehringer Ingelheim MEK program income, despite a tough operating environment, we see substantial room for growth. We remain committed to grow our US business both with our inline products as well as ramp up of Albuterol and Brovana, to continue above-market growth in India, and ensure growth in every part of the business. We see meaningful uplift in the second half and remain focused on our journey of expanding margins through driving strong double-digit revenue growth and optimizing costs, while ensuring the safety of our people and the highest standards of compliance."

Shares of Lupin Ltd was last trading in BSE at Rs. 1119.1 as compared to the previous close of Rs. 1133.95. The total number of shares traded during the day was 81269 in over 5116 trades.

The stock hit an intraday high of Rs. 1151.2 and intraday low of 1112.2. The net turnover during the day was Rs. 91972443.

Source : Equity Bulls

Keywords